|
ASAH2B expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.3664999999905E-06 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.818100E-03 |
| Normal-vs-Stage2 |
3.177900E-03 |
| Normal-vs-Stage3 |
9.63960000710529E-09 |
| Normal-vs-Stage4 |
4.90359997051826E-09 |
| Stage1-vs-Stage2 |
3.841400E-01 |
| Stage1-vs-Stage3 |
1.151020E-04 |
| Stage1-vs-Stage4 |
3.24330000001094E-06 |
| Stage2-vs-Stage3 |
6.718400E-02 |
| Stage2-vs-Stage4 |
1.431530E-02 |
| Stage3-vs-Stage4 |
3.592400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.27510000003106E-06 |
| Normal-vs-AfricanAmerican |
9.276700E-03 |
| Normal-vs-Asian |
9.705400E-01 |
| Caucasian-vs-AfricanAmerican |
5.178400E-01 |
| Caucasian-vs-Asian |
8.282000E-02 |
| AfricanAmerican-vs-Asian |
2.389600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.32350000003889E-06 |
| Normal-vs-Female |
5.411600E-04 |
| Male-vs-Female |
1.060840E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.276580E-03 |
| Normal-vs-Age(41-60Yrs) |
5.026100E-04 |
| Normal-vs-Age(61-80Yrs) |
9.95189999963841E-07 |
| Normal-vs-Age(81-100Yrs) |
9.424000E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.196400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.264200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.612800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.252400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.905800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.416600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.549600E-01 |
| Normal-vs-Grade 2 |
1.460410E-03 |
| Normal-vs-Grade 3 |
1.78567999999935E-05 |
| Normal-vs-Grade 4 |
8.60159998783416E-09 |
| Grade 1-vs-Grade 2 |
8.594400E-01 |
| Grade 1-vs-Grade 3 |
4.392800E-01 |
| Grade 1-vs-Grade 4 |
3.121500E-02 |
| Grade 2-vs-Grade 3 |
9.554300E-02 |
| Grade 2-vs-Grade 4 |
1.446170E-04 |
| Grade 3-vs-Grade 4 |
1.908310E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.234200E-02 |
| Normal-vs-ccB subtype |
8.40719999950501E-07 |
| ccA subtype-vs-ccB subtype |
9.823300E-04 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.218100E-04 |
| Normal-vs-N1 |
8.697400E-03 |
| N0-vs-N1 |
3.228400E-01 |
|
|
